AmerisourceBergen is one of the world's largest pharmaceutical services companies serving global markets with a focus on the pharmaceutical supply chain. Servicing both pharmaceutical manufacturers and healthcare providers, The Company provides drug distribution and related services designed to reduce costs and improve patient outcomes.

Employee Rating

3.0More
TypePublic
HQChesterbrook, US
Founded2001
Size (employees)19,000 (est)-5%
Websiteamerisourcebergen.com
AmerisourceBergen was founded in 2001 and is headquartered in Chesterbrook, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at AmerisourceBergen

Steven Collis

Steven Collis

Chairman, President and Chief Executive Officer
Kathy Gaddes

Kathy Gaddes

Executive Vice President and Chief Human Resources Officer
Albert Morales

Albert Morales

Chief Transformation Officer
Tim Guttman

Tim Guttman

Executive Vice President and Chief Financial Officer
John Chou

John Chou

Executive Vice President and Chief Legal & Business Officer
Gina Clark

Gina Clark

Executive Vice President and Chief Communications & Administration Officer
Show morewdxefcqufszuzezftuxetqsqxt

AmerisourceBergen Office Locations

AmerisourceBergen has an office in Chesterbrook
Chesterbrook, (HQ)
1300 Morris Dr
Show all (1)
Report incorrect company information

AmerisourceBergen Financials and Metrics

AmerisourceBergen Revenue

Embed Graph
View revenue for all periods
AmerisourceBergen's revenue was reported to be $167.94 b in FY, 2018
USD

Revenue (FY, 2018)

167.9b

Gross profit (FY, 2018)

4.6b

Gross profit margin (FY, 2018), %

2.7%

Net income (FY, 2018)

1.6b

EBIT (FY, 2018)

1.4b

Market capitalization (4-Dec-2018)

18.6b

Closing stock price (4-Dec-2018)

87.6

Cash (30-Sep-2018)

2.5b

EV

20.2b
AmerisourceBergen's current market capitalization is $18.6 b.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

119.6b136.0b146.8b153.1b167.9b

Revenue growth, %

36%14%8%4%

Cost of goods sold

116.6b132.4b142.6b148.6b163.3b

Gross profit

3.0b3.5b4.3b4.5b4.6b
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

29.2b28.5b30.3b33.6b32.7b34.2b36.7b35.7b36.9b38.2b37.1b38.7b40.5b81.5b43.1b

Cost of goods sold

28.5b27.7b29.7b32.8b31.8b33.3b35.7b34.6b35.8b37.1b35.9b37.6b39.4b79.1b41.9b

Gross profit

688.2m729.6m692.0m752.3m912.0m891.5m964.9m1.1b1.1b1.0b1.3b1.1b1.1b2.4b1.2b

Gross profit Margin, %

2%3%2%2%3%3%3%3%3%3%3%3%3%3%3%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

1.2b1.8b2.2b2.7b2.4b2.5b

Accounts Receivable

(1.3b)

Current Assets

14.4b16.8b20.3b22.9b24.3b25.9b

PP&E

803.6m899.6m979.3m1.5b1.8b1.9b
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

347.5m696.7m1.3b2.3b2.3b2.6b978.1m2.5b1.9b1.8b2.4b1.3b3.0b2.1b2.4b

Current Assets

15.2b15.8b15.9b20.1b19.6b19.9b20.4b22.1b21.5b23.1b23.5b23.7b25.3b26.4b26.4b

PP&E

824.1m850.8m882.2m907.0m955.6m958.7m1.1b1.1b1.2b1.6b1.7b1.7b1.8b1.9b1.9b

Goodwill

6.0b6.0b6.0b6.1b6.7b6.7b
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

433.7m276.5m(134.9m)145.7b364.5m1.6b

Depreciation and Amortization

237.1b

Accounts Payable

2.3b5.1b3.0b1.5b859.0m

Cash From Operating Activities

788.1m1.5b3.9b3.2b1.5b1.4b
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

41.4m221.5m208.7m(199.9m)(713.3m)(499.2m)330.4m934.5m1.3b247.2m658.7m709.1m861.9m1.1b1.4b

Accounts Payable

247.8m351.0m877.0m(59.2m)384.4m463.9m

Cash From Operating Activities

(1.0b)112.7m632.5m897.0m1.6b2.8b750.8m1.6b1.8b(430.4m)368.4m123.7m10.3m(77.2m)746.0m

Cash From Investing Activities

(68.2m)(128.1m)(319.2m)(77.2m)(2.7b)(2.7b)(2.8b)(2.9b)(3.0b)(156.9m)(269.5m)(406.6m)(142.3m)(935.4m)(1.0b)
USDY, 2018

EV/EBIT

14 x

EV/CFO

14.3 x

EV/FCF

18.8 x

Revenue/Employee

8.4m

Debt/Equity

1.4 x

Debt/Assets

0.1 x

Financial Leverage

12.4 x
Show all financial metrics

AmerisourceBergen Operating Metrics

FY, 2016

Countries

50

Distribution Centers

26
Show all operating metrics

AmerisourceBergen Acquisitions / Subsidiaries

Acquired CompanyDateDeal Size
MWI Veterinary SupplyJanuary 12, 2015$2.50 b
TheraComDecember 31, 2011$250 m
IntrinsiQSeptember 06, 2011$35 m

AmerisourceBergen Revenue Breakdown

Embed Graph

AmerisourceBergen revenue breakdown by business segment: 95.7% from Pharmaceutical Distribution and 4.3% from Other

Report incorrect company information

AmerisourceBergen Online and Social Media Presence

Embed Graph
Report incorrect company information

AmerisourceBergen News and Updates

Scott+Scott Attorneys at Law LLP Investigating Derivative Claims on Behalf of Shareholders of AmerisourceBergen Corporation - ABC

NEW YORK, Oct. 4, 2018 /PRNewswire/ -- Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, is investigating whether certain directors and officers of AmerisourceBergen Corporation ("AmerisourceBergen" or the "Company") (NYSE: ABC)...

Former AmerisourceBergen Executive Blows the Whistle on Massive Drug Overfill Laundering Scheme, Leading to $885 Million Combined Civil and Criminal Settlement

WASHINGTON, Oct. 1, 2018 /PRNewswire/ -- Whistleblower Law Collaborative and Kellogg, Hansen, Todd, Figel & Frederick, P.L.L.C. report Michael Mullen, the former chief operating officer of a subsidiary of AmerisourceBergen Corporation (NYSE: ABC), played an instrumental role in a landmark ...

AmerisourceBergen in $625 mln drug distribution settlement, New York says

AmerisourceBergen Corp will pay the U.S. government and various states $625 million to resolve claims over the illegal distribution of adulterated and misbranded drugs, New York Attorney General Barbara Underwood said on Monday.

AmerisourceBergen CEO Says Getting Employees to Think Big is Key to Success

Bold acquisitions and global expansion lifted Amerisource's ranking to number 12 on Fortune 500

Netskope Names AmerisourceBergen Winner of Cloud Security Excellence Award

LOS ALTOS, Calif., Aug. 8, 2018 /PRNewswire/ -- Netskope, the leader in cloud security, today named pharmaceutical company and Fortune 20 member AmerisourceBergen as the winner of the inaugural Cloud Security Excellence Award, recognizing the organization's commitment to secure cloud...

Christian Herrington, Veteran Pharmaceutical Business Executive, Joins HealthGrowth Capital's Advisory Board

AUSTIN, Texas, Aug. 6, 2018 /PRNewswire/ -- HealthGrowth Capital LLC, a leading alternative specialty lender to independent pharmacies and healthcare companies, is pleased to announce the appointment of Christian Herrington to the Company's Board of Advisors. "We are excited to welcome...
Show more
Report incorrect company information

AmerisourceBergen Company Life and Culture

Report incorrect company information

AmerisourceBergen Frequently Asked Questions

  • When was AmerisourceBergen founded?

    AmerisourceBergen was founded in 2001.

  • Who are AmerisourceBergen key executives?

    AmerisourceBergen's key executives are Steven Collis, Kathy Gaddes and Albert Morales.

  • How many employees does AmerisourceBergen have?

    AmerisourceBergen has 19,000 employees.

  • What is AmerisourceBergen revenue?

    Latest AmerisourceBergen annual revenue is $167.9 b.

  • What is AmerisourceBergen revenue per employee?

    Latest AmerisourceBergen revenue per employee is $8.8 m.

  • Who are AmerisourceBergen competitors?

    Competitors of AmerisourceBergen include McKesson, Cardinal Health and Henry Schein.

  • Where is AmerisourceBergen headquarters?

    AmerisourceBergen headquarters is located at 1300 Morris Dr, Chesterbrook.

  • Where are AmerisourceBergen offices?

    AmerisourceBergen has an office in Chesterbrook.

  • How many offices does AmerisourceBergen have?

    AmerisourceBergen has 1 office.